The high prevalence of the factor V Leiden mutation in central European inflammatory bowel disease patients [26]

American Journal of Gastroenterology

Volumn 95, Issue 10, 2000, Pages 3013-3014

  Nagy, Zsuzsanna ^a   Nagy, Ágnes ^a   Karádi, Oszkár ^a   Alajos Pár, Blank ^a   Mózsik, Gyula ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN;

CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; GENE MUTATION; HEMOSTASIS; HETEROZYGOTE; HUMAN; HUNGARY; LETTER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS;

EID: 0033793437     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02030-X     Document Type: Letter

References (4)

1. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease
2. Arg506Gln factor V mutation and Va134Leu factor XIII polymorphism in patients with inflammatory bowel disease
3. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease
4. An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease